Doctor of Philosophy in Pharmaceutical Sciences (PhD)
Degree:
Doctor of Philosophy
Specialization:
Pharmaceutical Sciences Quick Facts
Faculty:
Faculty of Pharmaceutical SciencesSubject:
Health and Medicine
Mode of delivery:
On campus
Registration options:
Full-time Application
Possible start dates:
| Deadlines for | ||
|---|---|---|
| Start date | Students with Canadian or US credentials | Students with international credentials |
| September | March 15th | February 15th |
Program contact details
Link to program website:
Application enquiries:
- Ms Rachel Wu, rachel.wu@ubc.ca
Please mail paper documents to:
George Cunningham Building
Graduate Office, 2146 East Mall
Vancouver
British Columbia, V6T 1Z3
Canada
Tuition / Program costs
| Fees | Canadian Citizen / Permanent Resident / Refugee / Diplomat | International |
|---|---|---|
| Application Fee | $91.80 | $153.00 |
| Tuition * | ||
| Installments per year | 3 | 3 |
| Tuition per installment | $1,449.72 | $2,546.90 |
| Tuition per year | $4,349.16 | $7,640.70 |
| Int. Tuition Award (ITA) per year (if eligible) | $3,200.00 (-) | |
| Other Fees and Costs | ||
| Student Fees (yearly) | $709.00 (approx.) | |
| Costs of living (yearly) | $16,763.00 (approx.) | |
* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.
Recent Doctoral Citations
- Dr. Fang Wang: "Dr. Wang revealed high blood glucose releases endothelial heparanase, while high fatty acids induces heparanase nuclear translocation during diabetes. These studies assist us in understanding the metabolism of heart, and may serve to reduce the cardiovascular complications associated with diabetes." (November 2011)
- Dr. Clement Mugabe: "Dr. Mugabe has developed novel formulations of anticancer drugs, known as paclitaxel and docetaxel. These novel formulations are based on small and adhesive nanoparticles and are used in the treatment of bladder cancer. Furthermore, these treatments have shown increased bladder tissue drug levels and efficacy in a mouse model of bladder cancer." (November 2011)
- Dr. Akhlaq Waheed Hakim: "Dr. Hakim demonstrated that jaw injections of the protein Tumour Necrosis Factor Alpha induced muscle pain through peripheral mechanisms without causing muscle damage. It was also found that this muscle sensitisation is mediated, in part, by increased levels of prostaglandin E2. These findings could be used to develop models of human jaw muscle pain." (May 2011)
- Dr. Ripen Misri: "Dr. Misri developed an imaging agent comprised of magnetic nanoparticles and radioactive antibodies for imaging cancers with SPECT and MRI. Such an imaging agent has application in the early detection and monitoring of mesotheliomas, pancreatic and ovarian cancers." (May 2011)
- Dr. Nilesh Patankar: "Dr. Patankar is helping to fight recurrent ovarian cancer. He demonstrated the benefit of incorporating the anti-cancer drug topotecan into lipid nanoparticles in order to improve its activity either as a stand-alone therapy or in combination with an existing formulation of doxorubicin which is already approved for use in patients." (May 2011)
Further Information
Link to UBC calendar:
UBC Calendar 
